Published by Josh White on 25th March 2019
(Sharecast News) - Biopharmaceutical company Ovoca Bio announced positive, statistically significant top-line results from a phase 3 clinical trial of its first candidate, 'Libicore' (BP-101), on Monday.
URL: http://www.digitallook.com/dl/news/story/28804364/...